J. Strand

发表

Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity

V. Tolmachev, A. Orlova, Mohamed Altai, 2015, ChemistryOpen.

188Re-ZHER2:V2, a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment

M. Lubberink, S. Strand, S. Ståhl, 2014, The Journal of Nuclear Medicine.

Agent Against HER2-Expressing Tumors:

M. Lubberink, S. Strand, J. Löfblom, 2014 .

Humanization, Radiolabeling and Biodistribution Studies of an IgG1-Type Antibody Targeting Uncomplexed PSA for Theranostic Applications

S. Strand, J. Strand, T. Tran, 2021, Pharmaceuticals.

PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates

S. Larson, H. Scher, R. Damoiseaux, 2020, Clinical Cancer Research.

Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of 68Ga-Compared to 111In-Labeled Conjugates

A. Karlström, V. Tolmachev, A. Orlova, 2014, Molecular imaging.

Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts

A. Karlström, V. Tolmachev, A. Orlova, 2013, PloS one.

Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo.

L. Abrahmsén, V. Tolmachev, A. Orlova, 2014, Molecular pharmaceutics.

Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde.

G. Antoni, V. Tolmachev, A. Orlova, 2014, Bioconjugate chemistry.

Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.

V. Tolmachev, A. Orlova, B. Mitran, 2016, Molecular pharmaceutics.

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

O. Nilsson, H. Lilja, S. Strand, 2012, Cancer biotherapy & radiopharmaceuticals.

Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA.

V. Tolmachev, A. Orlova, Mohamed Altai, 2013, Bioconjugate chemistry.

177Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α1-Microglobulin (A1M), Including Kidney Damage Assessment Using 99mTc-MAG3 Imaging

S. Strand, Mohamed Altai, A. Örbom, 2021, Biomolecules.

Hematological Toxicity in Mice after High Activity Injections of 177Lu-PSMA-617

S. Strand, Mohamed Altai, A. Örbom, 2022, Pharmaceutics.

Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re.

S. Ståhl, J. Löfblom, V. Tolmachev, 2014, European journal of medicinal chemistry.

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1125 Affibody Molecules for PET Imaging

J. Strand, 2015 .

Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules.

A. Karlström, V. Tolmachev, A. Orlova, 2012, Bioconjugate chemistry.

Affibody Molecules for PET Imaging

J. Strand, 2015 .

A Conjugation Strategy to Modulate Antigen Binding and FcRn Interaction Leads to Improved Tumor Targeting and Radioimmunotherapy Efficacy with an Antibody Targeting Prostate-Specific Antigen

S. Strand, Mohamed Altai, A. Örbom, 2021, Cancers.

HAHAHA-, HIHIHI-. HKHKHK. HHHHHH- and HEHEHE- tags : Influence of position and composition of histidine-containing tags on biodistribution of [99mTc(CO) 3]+- labeled affibody molecules

S. Hosseinimehr, V. Tolmachev, A. Orlova, 2013 .

HAHAHA, HEHEHE, HIHIHI, or HKHKHK: influence of position and composition of histidine containing tags on biodistribution of [(99m)Tc(CO)3](+)-labeled affibody molecules.

S. Hosseinimehr, V. Tolmachev, A. Orlova, 2013, Journal of medicinal chemistry.

Imaging of HER3-expressing xenografts in mice using a 99mTc(CO)3-HEHEHE-ZHER3:08699 affibody molecule

S. Ståhl, J. Löfblom, V. Tolmachev, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

V. Tolmachev, A. Orlova, K. Andersson, 2013, European Journal of Nuclear Medicine and Molecular Imaging.